Baseline characteristics.

Data are presented as mean ± standard deviation or as median with range.
‡) Cardiovascular disease was defined as ≥ 1 known conditions (placebo/ARB): Ischemic heart disease (9/8); arrhythmia (6/5); valvular disease (6/3); heart failure (0/1); LV: Left ventricular;
#)Tx: Kidney transplantation;
§) Charlson comorbidity index score range 0–37; 0 = low, 3+ = high; DDD = Defined daily doses; EPO: erythropoetin;
a) n = 39 (Placebo group);
b) n = 36 (Placebo group);
GFR: glomerular filtration rate based on the mean of urinary creatinine and urea clearance as previously described [25]; bpm: beats per minute; HDF: hemodiafiltration; HD: hemodialysis;
c) Three patients in the placebo group and two patients in the ARB group had dialysis vintage > one year and four patients (two in each group) had urine output < 300 mL/day due to delay after inclusion/screening.
Baseline characteristics.